Company intelligence / Profile preview
Medi-Radiopharma
- Ownership
- Private
- Employees
- ~38
- Development stage
- Commercial
Overview
Medi-Radiopharma is a leading Hungarian manufacturer of radiopharmaceuticals with over 25 years of experience. The company supplies sterile lyophilized drug products—primarily technetium cold kits—for diagnostic imaging to more than 70 countries. It is expanding into contract development/manufacturing services with a new facility near Budapest expected to open mid‑2025. The company maintains GMP certification, offers a broad product portfolio competing with major industry players, and continues to invest in R&D for both diagnostic and therapeutic nuclear medicine solutions.
- Therapeutic areas
- OncologyCardiovascularRheumatologyNeurology
- Modalities
- RadiopharmaceuticalsSterile injectable drug productsTheragnostic solutions (diagnostic and therapeutic radiolabeled compounds)
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Medi-Radiopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medi-Radiopharma.